Polymer free biolimus coated stents to treat acute ST‐elevation myocardial infarction in Asian patients
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.31263 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Paul J L Ong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mount Elizabeth Novena Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Cardiovascular Agents, Coronary Thrombosis, Drug-Eluting Stents, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Biosensors International Group.
Abstract (Originalsprache)
Background
Patients undergoing primary percutaneous coronary intervention (PPCI) for ST‐segment‐elevation myocardial infarction (STEMI) have a high thrombotic burden and often have a high bleeding risk (HBR). Asian patients have different patterns of thrombotic and bleeding risk from other populations which may be particularly relevant in the setting of PPCI for STEMI.
Objectives
To assess the safety and efficacy of the polymer free biolimus coated coronary stent (PF‐BCS, BioFreedom TM , Biosensors International) in Asian STEMI patients.
Methods
Patients with acute STEMI who received at least one PF‐BCS were invited to participate after their index procedure. Follow‐up was performed at 1, 4, and 12 months. The primary endpoint was the rate of target lesion failure (TLF) at 1 year. A performance goal was derived from the biolimus eluting stent arm of the COMFORTABLE AMI study which was the only prior dedicated study of biolimus eluting stents in patients with STEMI.
Results
A total of 914 patients with STEMI were enrolled. Mean patient age was 60 ± 13 years, diabetes was present in 23.2% and 43% were active smokers. According to the ARC definition, 12.4% of the patients were HBR. TLF rate was 2.54% [95% CI: 1.52–3.56], p ‐value for non‐inferiority
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mount Elizabeth Novena Hospital, Singapore, Singapore.
- Queen Elizabeth Hospital, Hong Kong, China.
- Queen Mary Hospital, Hong Kong, China.
- Hanoi Heart Hospital, Hanoi, Vietnam.
- Mackay Memorial Hospital, Taipei, Taiwan.
- Gachon University Gil Medical Center, Incheon, South Korea.
ORCID-Profile: Shing Fung Chui, Frankie Chor-Cheung Tam, Woong Chol Kang
Förderung
- Biosensors International Group
Zitieren
APA
Ong, P. J. L., Chui, S. F., Tam, F. C., Nguyen, Q. T., Tsai, C. T., Kang, W. C., Nuruddin, A. A., Singh, R., Chotinaiwattarakul, C., & Lee, M. (2024). Polymer free biolimus coated stents to treat acute ST‐elevation myocardial infarction in Asian patients. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31263
Vancouver
Ong PJL, Chui SF, Tam FC, Nguyen QT, Tsai CT, Kang WC, et al. Polymer free biolimus coated stents to treat acute ST‐elevation myocardial infarction in Asian patients. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31263
BibTeX
@article{Ong2024,
author = {Ong, Paul J L and Chui, Shing Fung and Tam, Frankie Chor-Cheung and Nguyen, Quang Tuan and Tsai, Cheng-Ting and Kang, Woong Chol and Nuruddin, Amin Arif and Singh, Ramesh and Chotinaiwattarakul, Chunhakasem and Lee, Michael},
title = {Polymer free biolimus coated stents to treat acute ST‐elevation myocardial infarction in Asian patients},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.31263}
}
EUVIMED